Joan Puig-Barbera

Summary

Affiliation: Hospital Universitario
Country: Spain

Publications

  1. ncbi [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis]
    J Puig-Barbera
    Grupo de Trabajo de Vacunas de la Sociedad Valenciana de Medicina de Familia y Comunitaria SVMFYC Promoción de Salud Centro de Salud Pública de Castellón Spain
    Aten Primaria 30:269-81; discussion 281-3. 2002
  2. ncbi Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age
    Joan Puig-Barbera
    Grupo de Trabajo Vacunas CAVA de la Sociedad Valenciana de Medicina Familiar y Comunitaria, Valencia, Spain
    Vaccine 23:283-9. 2004
  3. ncbi Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly
    Joan Puig-Barbera
    Fundación de la Sociedad Valenciana de Medicina de Familia y Comunitaria, Valencia, Spain
    Vaccine 25:7313-21. 2007
  4. ncbi MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations
    Joan Puig Barbera
    Centre de Salut Publica de Castello, Avda del Mar, 12, E 12100, Castello, Spain
    Expert Rev Vaccines 6:659-65. 2007
  5. doi Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study
    Joan Puig-Barbera
    Health Promotion Unit, Centro de Salud Pública, Avda del Mar, 12, 12003 Castellón, Spain
    Vaccine 28:7460-7. 2010
  6. doi MF59™-adjuvanted seasonal influenza vaccine in young children
    Joan Puig-Barbera
    Centro Superior de Investigación en Salud Pública, Centre for Public Health Research, Area of Vaccines Research, Avda Cataluña, 21, 46020 Valencia, Spain
    Expert Rev Vaccines 10:1519-28. 2011
  7. ncbi [Cardiac complications of major elective non-cardiac surgery: incidence and risk factors]
    Joan Puig-Barbera
    Centro de Salud Pública de Castellón, Castellon, Spain
    Rev Esp Cardiol 59:329-37. 2006
  8. ncbi [Immunisation: leaps into the future. Combined vaccines (I)]
    J Puig-Barbera
    Centro de Salud Pública de Castellón Grupo de Vacunas SVMFYC España
    Aten Primaria 31:453-7. 2003
  9. ncbi [Immunization: leaps into the future. Combined vaccines (II)]
    J Puig-Barbera
    Centro de Salud Pública de Castellón Grupo de Vacunas SVMFYC España
    Aten Primaria 31:601-5. 2003
  10. ncbi [Vaccines and pregnancy (part 2): protection of the newborn by vaccinating pregnant women]
    J Puig-Barbera
    Medico de Familia, Máster en Salud Pública, Grupo de Vacunas de la SVMFIC, Centro de Salud Pública de Castellón, Avenida del Mar 12, 12003 Castellón, Spain
    Aten Primaria 33:154-60. 2004

Collaborators

  • Javier Diez-Domingo
  • Alberto Arnedo-Pena
  • J Diez Domingo
  • Juan Bellido-Blasco
  • Soledad Márquez-Calderón
  • Santiago Perez-Hoyos
  • Juan B Bellido Blasco
  • Ana M Cebrián-Cuenca
  • Joan Puig Barbera
  • Nuria Morant-Talamante
  • Jorge Navarro-Pérez
  • Maria Rosario Pac-Sa
  • Alberto Arnedo
  • Alberto Arnedo Pena
  • Lina Pérez-Breva
  • Sergio Martínez-Úbeda
  • Sara Alemán-Sánchez
  • María San-Martín-Rodríguez
  • María San Martín Rodríguez
  • Francisca Cantos Fillols
  • Lorenzo Pascual-López
  • Carlos Momparler-Martínez
  • Elena Picón-García
  • Inmaculada Pereiró-Berenguer
  • Francisca Juan i Espert
  • Carmen Feliú-Morte
  • Margarita Colomer-Paché
  • Marco Antonio Latorre-Atienza
  • José Francisco Guillem-Miralles
  • Julia Cañada-Blasco
  • José Antonio Pla-García
  • José Enrique Mir-Mora
  • Inmaculada Cervera-Pérez
  • Ester Robles-Pastor
  • Daniel Matoses-Nácher
  • Leonor Vives-Rebollar
  • Carlos García-García
  • Roberto Gorgues-Comás
  • José Manuel Navarrete-Villalta
  • Nidia Ruiz-Varea
  • Marta Alvarez-Martínez
  • Antonio Roig López-De los Mozos
  • Adrián Artero-Sivera
  • Joan Baptista Campos-Cruañes
  • Lidón Museros-Recatalá
  • Ines Aguinaga-Ontoso
  • David González Vidal
  • Lidón Museros
  • Ester Tornador
  • Adrián Artero
  • María Rosario Pac
  • Ricardo Tosca
  • Joan Baptista Campos
  • Juan B Bellido
  • Francisco Pardo Serrano

Detail Information

Publications22

  1. ncbi [Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis]
    J Puig-Barbera
    Grupo de Trabajo de Vacunas de la Sociedad Valenciana de Medicina de Familia y Comunitaria SVMFYC Promoción de Salud Centro de Salud Pública de Castellón Spain
    Aten Primaria 30:269-81; discussion 281-3. 2002
    ..Estimate pneumococcal vaccine effectiveness in preventing Streptococcus pneumoniae illness in the elderly...
  2. ncbi Effectiveness of the MF59-adjuvanted influenza vaccine in preventing emergency admissions for pneumonia in the elderly over 64 years of age
    Joan Puig-Barbera
    Grupo de Trabajo Vacunas CAVA de la Sociedad Valenciana de Medicina Familiar y Comunitaria, Valencia, Spain
    Vaccine 23:283-9. 2004
    ....
  3. ncbi Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly
    Joan Puig-Barbera
    Fundación de la Sociedad Valenciana de Medicina de Familia y Comunitaria, Valencia, Spain
    Vaccine 25:7313-21. 2007
    ..31 [P=0.005] for pneumonia). During peak virus circulation, vaccination with MF59-adjuvanted subunit influenza vaccine was associated with an 87% relative risk reduction in hospitalisation for ACS, 93% for CVA, and 69% for pneumonia...
  4. ncbi MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations
    Joan Puig Barbera
    Centre de Salut Publica de Castello, Avda del Mar, 12, E 12100, Castello, Spain
    Expert Rev Vaccines 6:659-65. 2007
    ..This article summarizes the main characteristics of MF59-adjuvanted subunit influenza vaccine, the clinical effectiveness data that have been generated in recent years and future developments...
  5. doi Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study
    Joan Puig-Barbera
    Health Promotion Unit, Centro de Salud Pública, Avda del Mar, 12, 12003 Castellón, Spain
    Vaccine 28:7460-7. 2010
    ..However, the pandemic vaccine was associated with an adjusted vaccine effectiveness of 90% (95% CI, 48-100%). Pandemic vaccines were effective in preventing pandemic influenza associated hospitalizations...
  6. doi MF59™-adjuvanted seasonal influenza vaccine in young children
    Joan Puig-Barbera
    Centro Superior de Investigación en Salud Pública, Centre for Public Health Research, Area of Vaccines Research, Avda Cataluña, 21, 46020 Valencia, Spain
    Expert Rev Vaccines 10:1519-28. 2011
    ....
  7. ncbi [Cardiac complications of major elective non-cardiac surgery: incidence and risk factors]
    Joan Puig-Barbera
    Centro de Salud Pública de Castellón, Castellon, Spain
    Rev Esp Cardiol 59:329-37. 2006
    ..Our aims were to estimate the frequency of postoperative cardiac complications following major elective non-cardiac surgery in patients aged 40 years or more, and to identify associated risk factors...
  8. ncbi [Immunisation: leaps into the future. Combined vaccines (I)]
    J Puig-Barbera
    Centro de Salud Pública de Castellón Grupo de Vacunas SVMFYC España
    Aten Primaria 31:453-7. 2003
  9. ncbi [Immunization: leaps into the future. Combined vaccines (II)]
    J Puig-Barbera
    Centro de Salud Pública de Castellón Grupo de Vacunas SVMFYC España
    Aten Primaria 31:601-5. 2003
  10. ncbi [Vaccines and pregnancy (part 2): protection of the newborn by vaccinating pregnant women]
    J Puig-Barbera
    Medico de Familia, Máster en Salud Pública, Grupo de Vacunas de la SVMFIC, Centro de Salud Pública de Castellón, Avenida del Mar 12, 12003 Castellón, Spain
    Aten Primaria 33:154-60. 2004
  11. ncbi [Vaccinations and pregnancy (I): vaccines that are indicated for pregnant women]
    J Puig-Barbera
    Salud Pública, Grupo de Vacunas de la SVMFIC, Centro de Salud Pública de Castellón, Castellon, Espana
    Aten Primaria 33:38-43. 2004
  12. ncbi Varicella vaccine effectiveness during an outbreak in a partially vaccinated population in Spain
    Alberto Arnedo-Pena
    Epidemiology Division, Castellón Public Health Centre, Castellon, Spain
    Pediatr Infect Dis J 25:774-8. 2006
    ..Although the varicella vaccine is not included in the infant vaccination program, some children had been vaccinated before the outbreak...
  13. ncbi [Risk factors for symptoms of allergic rhinitis in adolescents in Castellón, Spain]
    Maria Rosario Pac-Sa
    Oficina Plan del Cáncer, Conselleria de Sanitat, Valencia, Espana
    Rev Panam Salud Publica 23:333-40. 2008
    ..To estimate the risk factor for symptoms of allergic rhinitis in adolescents in Castellón, Spain...
  14. ncbi [Domestic water hardness and prevalence of atopic eczema in Castellon (Spain) school children]
    Alberto Arnedo-Pena
    Sección de Epidemiología, Centro Salud Pública, Castellon, Spain
    Salud Publica Mex 49:295-301. 2007
    ..Water hardness has been associated with atopic eczema (AE) prevalence in two epidemiologic studies carried out on schoolchildren in England and Japan...
  15. pmc Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain
    Ana M Cebrián-Cuenca
    Centro de Salud de Ayora, Avenida Argentina, Ayora, Valencia, Spain
    BMC Infect Dis 11:302. 2011
    ..The present study aimed to estimate the clinical and economic burden of HZ and PHN in Valencia (Spain)...
  16. doi Pharmacoeconomic assessment of implementing a universal PCV-13 vaccination programme in the Valencian public health system (Spain)
    Javier Diez-Domingo
    Centro Superior de Investigación en Salud Pública, Valencia, Spain
    Vaccine 29:9640-8. 2011
    ..pneumoniae. Thirteen-valent pneumococcal conjugate vaccine (PCV-13) includes 6 additional serotypes for preventing invasive pneumococcal disease...
  17. ncbi [Incidence of asthma and risk factors in a cohort of schoolchildren aged from 6-7 years old to 14-15 years old in Castellón (Spain) following the International Study of Asthma and Allergies in Childhood (ISAAC)]
    Alberto Arnedo
    Sección de Epidemiología, Centro Salud Pública, Castellon, Espana
    Med Clin (Barc) 129:165-70. 2007
    ..To estimate the incidence of asthma in schoolchildren from 6-7 years old to 14-15 years old and associated risk factors...
  18. pmc Epidemiology of herpes zoster infection among patients treated in primary care centres in the Valencian community (Spain)
    Ana M Cebrián-Cuenca
    Centro Superior de Investigaciones en Salud Pública de Valencia CSISP, Av, Cataluña 21, 46020, Valencia, Spain
    BMC Fam Pract 11:33. 2010
    ..There is little available data regarding the epidemiology of herpes zoster (HZ) in Spain. This study's main goal was to estimate the annual incidence of HZ in the Autonomous Community of Valencia...
  19. doi Antibody persistence 12 months after a booster dose of meningococcal-C conjugated vaccine in the second year of life
    Javier Diez-Domingo
    Centro Superior de Investigación en Salud Pública, Valencia, Spain
    Pediatr Infect Dis J 29:768-70. 2010
    ..4-616.3) were higher in children receiving the meningococcal serogroup C tetanus toxoid conjugate, compared with 61.5% and serum bactericidal antibody geometric mean titer of 45.1 (95% CI: 28.5-71.3) when MenC-CRM197 conjugate was used...
  20. doi Risk factors and prevalence of asthma in schoolchildren in Castellon (Spain): a cross-sectional study
    Alberto Arnedo-Pena
    Sección de Epidemiología, Centro Salud Pública, Castellon, Spain
    Allergol Immunopathol (Madr) 37:135-42. 2009
    ..Research on potential risk factors of asthma can enhance our understanding of geographic differences and inform decisions on preventive strategies...
  21. ncbi [Varicella outbreak in a work center for psychologically handicapped adults]
    Alberto Arnedo Pena
    Sección de Epidemiología, Centro de Salud Pública de Castellón, Castellon, Spain
    Med Clin (Barc) 125:95-7. 2005
    ..An outbreak of varicella is described in a training and work center for psychologically handicapped adults with a high susceptibility to the disease...
  22. pmc Herpes zoster surveillance using electronic databases in the Valencian Community (Spain)
    Nuria Morant-Talamante
    Vaccine Research Area, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region FISABIO Public Health, Valencia, Spain
    BMC Infect Dis 13:463. 2013
    ..Epidemiologic data of Herpes Zoster (HZ) disease in Spain are scarce. The objective of this study was to assess the epidemiology of HZ in the Valencian Community (Spain), using outpatient and hospital electronic health databases...